{"slideshow_credits": null, "snippet": "The 21st Century Cures Act could substantially lower the standards for approval of many medical products, potentially placing patients at unnecessary risk.", "abstract": "Op-Ed article by policy experts Gregg Gonsalves, Mark Harrington and David A Kessler staunchly opposes passage of the 21st Century Cures Act; warns act could lower standards for approval of medical products and place patients at potential risk; traces history of current FDA approval standards to AIDS crisis in the 1980s, saying new policies will disrupt a system that is agile and effective.", "section_name": "Opinion", "print_page": "27", "document_type": "article", "byline": {"person": [{"firstname": "Gregg", "role": "reported", "lastname": "GONSALVES", "rank": 1, "organization": ""}, {"firstname": "Mark", "role": "reported", "lastname": "HARRINGTON", "rank": 2, "organization": ""}, {"lastname": "KESSLER", "rank": 3, "firstname": "David", "role": "reported", "organization": "", "middlename": "A."}], "original": "By GREGG GONSALVES, MARK HARRINGTON and DAVID A. KESSLER"}, "web_url": "http://www.nytimes.com/2015/06/11/opinion/dont-weaken-the-fdas-drug-approval-process.html", "lead_paragraph": "The 21st Century Cures Act could substantially lower the standards for approval of many medical products, potentially placing patients at unnecessary risk.", "headline": {"print_headline": "Don\u2019t Rush Drugs to Market", "main": "Don\u2019t Weaken the F.D.A.\u2019s Drug Approval Process", "content_kicker": "Op-Ed Contributors", "kicker": "Op-Ed Contributors"}, "_id": "557936f338f0d808b502d436", "word_count": "777", "multimedia": [{"height": 126, "url": "images/2015/06/11/opinion/11Gonsalves/11Gonsalves-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/06/11/opinion/11Gonsalves/11Gonsalves-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 438, "url": "images/2015/06/11/opinion/11Gonsalves/11Gonsalves-articleLarge.jpg", "legacy": {"xlarge": "images/2015/06/11/opinion/11Gonsalves/11Gonsalves-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "438"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/06/11/opinion/11Gonsalves/11Gonsalves-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/06/11/opinion/11Gonsalves/11Gonsalves-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-06-11T00:00:00Z", "source": "The New York Times", "news_desk": "OpEd", "keywords": [{"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Medical Devices", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Acquired Immune Deficiency Syndrome", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Regulation and Deregulation of Industry", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Act Up", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "National Institutes of Health", "is_major": "N", "rank": "7"}, {"name": "glocations", "value": "United States", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": null, "type_of_material": "Op-Ed"}